Načítá se...
Role of Novel Oral Anticoagulants in the Treatment of Antiphospholipid Syndrome
Background: Antiphospholipid syndrome (APS) is an autoimmune disease characterized by thrombosis or pregnancy loss with persistent positive antibodies. Standard treatment for APS with history of thromboembolism is heparin or low-molecular-weight heparin followed by a vitamin K antagonist (VKA). Nove...
Uloženo v:
| Vydáno v: | Hosp Pharm |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Thomas Land Publishers, Inc.
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5080995/ https://ncbi.nlm.nih.gov/pubmed/27803506 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1310/hpj5109-759 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|